First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2
Building on this momentum, the company is advancing its late-stage pipeline with several therapies nearing regulatory approval. Among these are zongertinib for HER2-mutant lung cancer and nerandomilast for pulmonary fibrosis, both of which recently delivered positive pivotal results and are progressing towards potential launches in the second half of 2025.
'At Boehringer Ingelheim, our commitment to transforming lives for generations is more than a mission — it's a responsibility we carry forward every day. Therapies like JARDIANCE® and OFEV® continue to make a real difference to patients — they exemplify what's possible when true innovation addresses unmet medical needs,' said Shashank Deshpande, Chairman of the Board of Managing Directors and Head of Human Pharma. 'At the same time, we're making strong progress across our pipeline — from obesity to liver and kidney health — with the goal of redefining standards of care. As we prepare for the potential launches of zongertinib and nerandomilast later this year, we remain focused on delivering meaningful solutions. We understand the urgency behind every patient's need, and we're acting with speed and purpose to meet it.'
Frank Hübler, Member of the Board of Managing Directors responsible for Finance, added: 'In a volatile environment, we are delivering according to plan, with robust sales performance across our portfolio in human and animal health. As we prepare for major launches, we are investing more than ever – focusing on speed, scale, and impact to ensure we are ready to deliver innovative therapies to change the course of serious diseases. Beyond the excitement of new launches, we also see substantial growth potential in our established products, particularly with JARDIANCE®, which continue to make a meaningful difference for patients worldwide.'
Human Pharma
In the first half of 2025, Boehringer Ingelheim's Human Pharma business grew 5.7%* reaching EUR 11.3 billion in net sales. Growth was driven by solid global demand for key products, including EUR 4.3 billion in sales from JARDIANCE®, the treatment of chronic kidney diseases, type 2 diabetes and heart failure, and EUR 2.0 billion in sales from OFEV®, which is used to treat idiopathic pulmonary fibrosis and certain fibrosing interstitial lung diseases.
Boehringer Ingelheim's human pharma pipeline is strong, with over ten new Phase II and III trials starting in the next 12 to 18 months across our multiple therapeutic areas. These could lead to major product launches over the next five years, offering the potential to transform millions of lives. U.S. launches for zongertinib and nerandomilast are expected in the second half of 2025, pending FDA approval.
Zongertinib, a targeted therapy for HER2-mutant advanced non-small cell lung cancer (NSCLC), showed durable response and clinically meaningful results in previously treated patients, with more than 70% of patients experiencing a tumor response. It is under regulatory review in U.S., Japan and China and being studied as a first-line treatment in a global Phase III trial. If approved, it would become the first orally administered targeted treatment for previously treated HER2-mutated lung cancer patients.
Nerandomilast, a potential therapy for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), significantly slowed lung-function decline in the two FIBRONEER™ Phase III trials. It was well tolerated, with discontinuation rates comparable to placebo. Regulatory submissions have been made in the U.S., EU, China and Japan. The company also launched a Phase III trial for our DPP1/CatC inhibitor verducatib (BI 1291583) to evaluate its potential in treating bronchiectasis. Verducatib received FDA breakthrough therapy designation in 2024.
In cardiovascular, renal, and metabolic (CRM) diseases, Boehringer Ingelheim started two new Phase III trials under the ongoing EASi trial program. In these trials, the company is investigating the potential benefits of an aldosterone synthase inhibitor/SGLT2i therapy in people with chronic heart failure and for cardiovascular risk reduction in people with type 2 diabetes, high blood pressure and cardiovascular disease.
To support future launches and continued growth, the company is continuing to strengthen its global supply network. A key milestone is the EUR 300 million investment in its Yamagata site in Japan, with the opening of a new production unit, infrastructure measures and groundbreaking for an additional facility began in June. This expansion will position Japan as a critical production hub for the Asia and Oceania regions. At the same time Boehringer continues to strengthen its local production network in the USA, building on existing partnerships.
Animal Health
In the first six months of 2025, Boehringer Ingelheim's Animal Health Business delivered strong growth, with net sales increasing by 7.6%* to EUR 2.6 billion. This performance was driven by continued momentum in the parasiticide portfolio, particularly the NEXGARD® brand, which grew by 7.9%*.
A key growth driver in Europe was BULTAVO 3™, a newly launched vaccine that protects cattle and sheep against bluetongue virus serotype 3 (BTV-3). BULTAVO 3™ is the first vaccine to prevent both clinical signs and mortality from BTV-3 and has been licensed in several European countries.
The company also expanded its vaccine portfolio with the launch of VAXXITEK® HVT+IBD+H5, a trivalent poultry vaccine, offering protection against Marek's disease, Infectious Bursal Disease, and H5 avian influenza in a single shot. It was first introduced in Egypt in early 2025 and is designed for administration directly at the hatchery, providing early protection for chicks. In the companion animal segment, Boehringer Ingelheim entered a strategic digital health collaboration with Eko Health to improve early detection of heart disease in dogs. The partnership combines Boehringer's expertise in canine cardiology with Eko's AI-powered stethoscope technology, aiming to launch a dedicated mobile app for veterinarians in 2026.
Outlook
As Boehringer Ingelheim enters the second half of 2025, the company is well-positioned to build on its first-half year performance and expects a positive year-on-year increase in net sales. With major product launches, a robust pipeline, and strategic investments in R&D and manufacturing,
Boehringer Ingelheim is set to expand its global impact and bring innovative health solutions to more patients and animals worldwide.
Visit our half-year financial highlights page
HERE
.
* on a comparable basis (adjusted for currency and other effects)
Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at
www.boehringer-ingelheim.com
.
Intended Audiences Notice
This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) ('KORU Medical' or the 'Company'), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced inducement equity awards to Adam Kalbermatten, Chief Commercial Officer, pursuant to his previously announced employment agreement with the Company dated as of June 30, 2025. Mr. Kalbermatten was granted nonqualified stock options on August 1, 2025 to purchase 600,000 shares of the Company's common stock at an exercise price of $3.44 per share. In addition, on July 28, 2025, his start date, Mr. Kalbermatten received 300,000 restricted shares of the Company's common stock. Each of these awards are subject to vesting 25% on each anniversary of their grant date, subject to accelerated vesting and the other terms and conditions of the respective award agreements entered into between Mr. Kalbermatten and the Company. The Compensation Committee of the Company's Board of Directors approved the awards as an inducement material to Mr. Kalbermatten's employment in accordance with Nasdaq Listing Rule 5635(c)(4). About KORU Medical Systems KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the 'Freedom System') currently includes the Freedom60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Services and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit
Business Insider
an hour ago
- Business Insider
Use these money management tips to potentially help build a stronger financial future for your business
Starting a small business and being self-employed is exciting, but it requires a lot of time and work. A self-employed person can wear many hats or titles on any given day, including chief marketing officer, sales manager, customer service department head, and accountant. Multitasking, juggling multiple priorities, poor cash flow, and a general lack of time/energy are the primary reasons that small businesses don't thrive. Here are a few business strategies to help your business run smoother. Separate personal from business It's tempting to use existing personal credit cards, along with bank and savings accounts, for business purposes, particularly when you're getting started. But a separate setup for business income and expenses helps delineate the two, simplifies tax preparation, and may reduce personal liability. Consider multiple accounts for your business One tip for accommodating different business needs — taxes, operating expenses, and an emergency fund — is to find a financial institution that allows you to have linked yet separate accounts or funds. Once you do that, automatically divvy up every invoice payment as needed into various accounts. Figure out a digital record-keeping system you like What works for you may not work for someone else, so review the options in software programs to find out what fits your accounting style. Some have a small monthly fee but allow you to generate branded invoices and offer payment collection and tracking, account reconciliation, and custom reports for tax purposes. Create an expense tracking routine Recording your business expenses can help reduce your tax burden, but it's also imperative to maintain accurate records. Save receipts and statements, and consider a quick-scan program to keep digital copies. Use your digital record-keeping system to collect data and find a tool that helps you track business-related mileage. E-pay and e-invoice, if you can Switching to these options can help you get in the habit of immediate billing and allow people to send you money efficiently. In addition, many online processors integrate with most bookkeeping or invoicing systems to allow for seamless record-keeping collection. Consider using a tax professional When you work for yourself, taxes can be confusing and tricky. They involve not only Social Security and Medicare but also 1099s, itemizing, and quarterly payments. Investing in the services of an expert may pay off by saving you time and reducing the possibility of mistakes and fines. Review your insurance needs There are many questions you should ask regarding your business and personal insurance coverages. What would you do if you were sued? What if you couldn't work for a month? What will happen to your business when you die? Contact a State Farm® agent to review coverages such as workers' compensation coverage, commercial umbrella insurance, disability insurance, life insurance, business and professional liability insurance, health insurance, and more. Save for retirement There are retirement plan options every business owner should consider. Many self-employed people do not have a plan. Take time to review which retirement savings plan option would be best for you. Plan for the unexpected What will happen to your business after you are gone or if you become disabled? Business continuation is an important topic to consider for most small business owners. A will or trust does not always address the central problems created when this happens. This is particularly important when there are stockholders or other people who have an interest in your business. Learn more about State Farm resources available for your small business. If you're ready to get a small business insurance quote, fill out this form, and a State Farm agent will reach out to you. This post was created by State Farm with Insider Studios. _________________________________________________________________________ The information in this article was obtained from various sources not associated with State Farm® (including State Farm Mutual Automobile Insurance Company and its subsidiaries and affiliates). While we believe it to be reliable and accurate, we do not warrant the accuracy or reliability of the information. State Farm is not responsible for, and does not endorse or approve, either implicitly or explicitly, the content of any third party sites that might be hyperlinked from this page. The information is not intended to replace manuals, instructions or information provided by a manufacturer or the advice of a qualified professional, or to affect coverage under any applicable insurance policy. These suggestions are not a complete list of every loss control measure. State Farm makes no guarantees of results from use of this information. Neither State Farm nor its agents provide tax or legal advice. State Farm Mutual Automobile Insurance Company State Farm Indemnity Company State Farm Fire and Casualty Company State Farm General Insurance Company State Farm Mutual Automobile Insurance Company State Farm Life Insurance Company (Not licensed in MA, NY or WI) State Farm Life and Accident Assurance Company (Licensed in NY and WI) Bloomington, IL State Farm County Mutual Insurance Company of Texas State Farm Lloyds Richardson, TX State Farm Florida Insurance Company Tallahassee, FL
Business Wire
2 hours ago
- Business Wire
Viking Opens Bookings for 2027–2028 Ocean and Expedition Voyages
LOS ANGELES--(BUSINESS WIRE)--Viking® ( (NYSE: VIK) today announced that its 2027–2028 ocean and expedition voyages are now open for booking. With destination-focused journeys on all seven continents, additional departures are now available across Viking's award-winning ocean and expedition fleet, including the company's most popular itineraries. The new sailing dates include voyages on Viking's newest ocean ship, the Viking Lyra®, which is scheduled to join the fleet in 2028 and will spend her inaugural season in the Mediterranean and Scandinavia. As part of today's announcement, Viking also unveiled a new expedition itinerary, Into the Antarctic Circle, which will offer travelers the rare opportunity to cross the 66°33′ line of latitude, which marks the Antarctic Circle, while exploring the 'White Continent' – an honored milestone among polar explorers. 'Our guests are curious travelers who like to connect with the destinations they visit in a meaningful way,' said Torstein Hagen, Chairman and CEO of Viking. 'We have always crafted journeys that are designed to bring our guests closer to history, culture and nature in each destination—and we are pleased to offer an even wider selection of itineraries and departure dates in the years to come.' With a fleet of small, all-veranda sister ships designed specifically for ocean voyages and state-of-the-art Polar Class expedition ships, Viking offers more than 100 itineraries across all five oceans and on all seven continents. The 2027–2028 deployment expands the company's offerings on its most popular and new voyages, including: NEW for 2027 Into the Antarctic Circle (15 days; Buenos Aires – Ushuaia) – Enter the pristine world of the 'White Continent' and sail across the 66°33′ line of latitude into the Antarctic Circle. Venture into this untouched polar region that teems with remarkable wildlife and is visited by only a rare few. Navigate narrow channels by Zodiac, kayak ice-laden waters and participate in meaningful science with resident experts from partner organizations such as the University of Cambridge's Scott Polar Research Institute and UC San Diego's Scripps Institution of Oceanography and J. Craig Venter Institute. A voyage of discoveries and sheer wonder awaits on this extended itinerary that goes beyond mere sightseeing. South America & the Chilean Fjords (18 days; Buenos Aires – Santiago) – Soak in the eclectic mix of Latin and European influences in the Argentine capital of Buenos Aires, the birthplace of tango. Visit Port Stanley, home to more than one million penguins, and explore the scenic surroundings of Ushuaia, the city at the 'End of the World.' Sail through the Strait of Magellan, passing rugged mountain peaks and blue-tinted icebergs and experience Chile's vibrant capital city, Santiago. Viking Homelands (15 days; Stockholm – Bergen) – Sail the clear waters of Scandinavia and the Baltic on this 15-day voyage. Delve deeper with overnight stays in the refined capital of Stockholm, the culturally rich city of Oslo and the picturesque coastal city of Bergen. Discover the charming historic center of Tallinn and marvel at the Gothic brick cathedrals in Gdańsk. Immerse yourself in Norwegian culture in Stavanger and Eidfjord and view breathtaking scenery from your ship as she glides through majestic fjords in the legendary homelands of the Vikings. Australia & New Zealand (15 days; Sydney – Auckland) – Gain a deep understanding of the native and European influences that shape Australia and New Zealand. Learn about Australia's penal past from a descendant of its first settlers. Admire the Victorian treasures of Dunedin, the fragrant English gardens of Christchurch and the art deco glories of Napier. Enjoy the sounds of the didgeridoo from Indigenous Australians and watch the captivating dances of the Māori. With Viking, every moment is designed to immerse you in the rich heritage of these southern lands. British Isles Explorer (15 days; Bergen—London) – Journey through the storied landscapes of the British Isles and explore Norway's charming city of Bergen. Discover the legendary Highlands and Western Isles of Scotland and its capital, Edinburgh. Visit the Shetland and Orkney Islands and contrast modern Belfast with traditional Dublin. Experience Welsh culture in Snowdonia. In England, visit Liverpool, home of the legendary Beatles and the 'World Capital of Pop,' see historic Dover and its dramatic white chalk cliffs and overnight in Greenwich, a borough of London and home to several iconic maritime institutions. Great Lakes Collection (15 days; Toronto – Duluth) – Join Viking for a unique voyage across the historic waterways of all five of the majestic Great Lakes. Sail scenic shorelines, explore storied cities and admire the awesome power of the thundering Niagara Falls. Navigate the granite islands and sheltered inlets of Georgian Bay and traverse the famous Soo Locks. Study the aquatic ecosystems of the lakes as you journey and venture into the dense boreal forests that line the shores of Lake Superior and Lake Michigan. Far Eastern Horizons (15 days; Hong Kong – Tokyo) – Unravel the mysteries of one of the most captivating corners of Asia. Browse the lively stalls at Hong Kong's renowned Stanley Market. Gain a deeper understanding of Taiwan through the perspective of a local guide. In Japan, hear firsthand accounts from residents of Nagasaki and Hiroshima. Uncover the vibrant contrasts of Shimizu and Tokyo with insights from those who live there. With overnight stays in four ports, you will have the time to explore each destination in greater depth. Into the Northwest Passage (13 days; roundtrip Nuuk) – Discover the rugged landscapes and awe-inspiring nature of the Arctic Circle. Immerse yourself in Inuit customs and traditions while exploring towns dotted with colorful wooden houses. See the towering peaks of Greenland and the blue-tinged glaciers of the Canadian High Arctic, as you kayak pristine fjords, or partake in a Zodiac shore landing. Join Viking on a once-in-lifetime voyage to remote territories and stunning natural wonders. Alaska & the Inside Passage (11 days; Vancouver – Seward) – Immerse yourself in Tlingit culture and experience the outpost atmosphere that prevails in charming, mountain-ringed seaside towns. Sail a pristine wilderness of misty fjords, lush forests and gleaming walls of ice, pan for gold like prospectors of old and hear tales of a region where a Wild West spirit still feels very much alive. Classic Panama Canal Passage (11 days; Ft. Lauderdale – Panama City) – Immerse yourself in nature and discover the colonial gems of Central America. Set sail and relax in the serene surroundings of Cozumel on the east coast of Mexico's Yucatan Peninsula. Discover the ancient Mayan civilization in Belize and explore the lush rainforests of Costa Rica. Embark on a crossing of Panama's famed canal, an engineering marvel, and witness centuries-old tribal life as you experience the traditions of the Emberá people. Empires of the Mediterranean (10 days; Venice – Athens) – Ten days. Nine magnificent destinations. One epic journey. Sail the Adriatic and Aegean, taking in all the riches of this fabled region. On an exploration bookended by iconic Venice and Athens, discover the ancient ruins of Olympia and the Acropolis. Explore the medieval warrens of Zadar and Dubrovnik and admire the famed whitewashed villages of Santorini. Delight in the beauty of Corfu and be captivated by Koper, the gateway to picturesque Slovenia. Iceland's Natural Beauty (8 days; roundtrip Reykjavik) – Discover Iceland's majestic shores as you explore this northern isle's coastal towns. Encounter unparalleled natural beauty and see cascading waterfalls amid pristine fjords. Discover Viking heritage as you follow in the footsteps of intrepid Norse explorer Leif Eriksson, widely regarded as the first European to set foot in North America. Or observe the remarkable diversity of wildlife, from puffins and Arctic foxes to seals and whales. Join us for a truly immersive experience that brings you closer to nature and all her splendor. Iconic Western Mediterranean (8 days; Barcelona – Rome) – France's famed southern coast and Italy's Renaissance treasures take center stage on this eight-day Mediterranean sojourn. Immerse yourself in Catalonian and Tuscan art, architecture and history during overnights in Barcelona and Tuscany. In the South of France, call on historic Montpellier and picturesque Marseille and visit Monte Carlo, Monaco's glamorous city by the sea. Viking's Award-Winning Fleet Viking was rated #1 for Oceans, #1 for Rivers and #1 for Expeditions by Condé Nast Traveler in the 2024 Readers' Choice Awards for the second consecutive year. Viking was also named a 'World's Best' for oceans, rivers and expeditions in Travel + Leisure's 2025 World's Best Awards. No other travel company has simultaneously received the same honors from both publications. In the 2025 World's Best Awards, Viking was once again named #1 for Expeditions, a position it has maintained since its first year of eligibility in that category. Viking was named Best Luxury Line, Best Line for Couples and Best Line in the Mediterranean in U.S. News & World Report's 2025 Best Cruise Lines ranking for the fourth consecutive year. Viking's ocean ships have also been rated and 'Recommended' as part of the Forbes Travel Guide 2024 Star Awards, an annual independent evaluation for luxury travel brands. Additionally, Cruise Critic honored Viking with seven awards across the Luxury (Ocean), River and Expedition categories 2024 Best in Cruise Awards. One Viking Designed for curious travelers, Viking's river, ocean and expedition voyages bring guests to the heart of enriching destinations on all seven continents. From Europe's iconic waterways and the storied shores of the Mediterranean to the Canadian High Arctic and Antarctica, the Viking experience is singular. To learn more, visit Booking Details From now through August 31, 2025, Viking is offering North American travelers the Summer Sale, with reduced fares on all-inclusive voyages, with up to free international airfare and a $25 deposit. Call Viking toll free at 1-800-2-VIKING (1-800-284-5464) or contact a travel advisor for booking details. Media Assets For more information about Viking, or for images and b-roll, please contact vikingpr@ About Viking Viking (NYSE: VIK) was founded in 1997 and provides destination-focused journeys on rivers, oceans and lakes around the world. Designed for curious travelers with interests in science, history, culture and cuisine, Chairman and CEO Torstein Hagen often says Viking offers experiences For The Thinking Person™. Viking has more than 450 awards to its name, including being rated #1 for Rivers, #1 for Oceans and #1 for Expeditions by Condé Nast Traveler in the 2023 and 2024 Readers' Choice Awards. Viking is also rated a 'World's Best' for rivers, oceans and expeditions by Travel + Leisure. No other travel company has simultaneously received the same honors by both publications. For additional information, contact Viking at 1-800-2-VIKING (1-800-284-5464) or visit For Viking's award-winning enrichment channel, visit
